16
Jun
2026

Jiangsu Nhwa Pharmaceutical Co., Ltd.

Exhibitor at CPHI & PMEC China 2026 stand W3C50, Pharma Ingredients
About Us

Nhwa is specialized in R&D, manufacturing and trading of APIs and dosages in the field of Central Nervous System. With more than 50 years of unremitting endeavor and prominent reputation, Nhwa has become the leader of manufacturing CNS drugs in China.

  • Country/Region:
    China
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
Contact info
  • No.18, Yangshan Road, Economic Development Zone, 221009, Xuzhou, Jiangsu , China
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W3C50, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • Alpha-(2,4-dichlorophenyl)-1h-imidazole-1-ethanol

    Product Alpha-(2,4-dichlorophenyl)-1h-imidazole-1-ethanol

    Jiangsu Nhwa Pharmaceutical Co. Ltd offers wide range of API which includes alpha-(2,4-dichlorophenyl)-1h-imidazole-1-ethanol. It belongs to anti fungal category. Contact us for more information.
  • Aripiprazole

    Product Aripiprazole

    Jiangsu Nhwa Pharmaceutical Co. Ltd offers wide range of API which includes aripiprazole. It belongs to central nervous system category. Contact us for more information.
  • Bifonazole

    Product Bifonazole

    Jiangsu Nhwa Pharmaceutical Co. Ltd offers wide range of API which includes bifonazole. It belongs to anti fungal category. Contact us for more information.
  • Buspirone  hcl

    Product Buspirone  hcl

    Jiangsu Nhwa Pharmaceutical Co. Ltd offers wide range of API which includes buspirone  hcl. It belongs to central nervous system category. Contact us for more information.
  • Citalopram hbr

    Product Citalopram hbr

    Jiangsu Nhwa Pharmaceutical Co. Ltd offers wide range of API which includes citalopram hbr. It belongs to central nervous system category. Contact us for more information.